Differently from MTF, both pharmacologic H6PD impairment by CBX and selective silencing of its expression decreased overall glucose consumption of studied cancer cells suggesting an energetic role for ER metabolism independent from OXPHOS. The gene discussed is H6PD; the disease is cancer.